Pharmaceutical Executive
Ilogistica has built a brand new warehouse facility with the latest technology to keep up with outsourcing demands
With the reform of CENABAST requiring the outsourcing of all its distribution activities, logistics providers are stepping up to meet the demand of pharmaceutical laboratories. Just outside of Santiago, iLogistica has built a brand new 8,000m2 storage warehouse with the latest technology for the most efficient distribution of pharmaceutical products. Having reconstructed almost from scratch after the earthquake in February of 2010, the company has refurbished itself to become the strategic partner for the industry. General manager, Raul Zamorano, explains his company's comparative advantage to serve the pharmaceutical industry: "being an entirely independent company that is not linked to any pharmaceutical laboratory, we can ensure the utmost confidentiality of our clients' data and product information. We also have no alliance with any of the players in the industry and this allows us to act freely always looking to serve our clients in the most efficient and effective way possible. In this sense we are positioned to become a trustworthy partner for any international company that wishes to distribute their products in Chile and who might have reservations about the safety of their company's data." The company has gone as far as developing a custom-made software platform that allows the greatest adaptability to the demands of its customers. "In order to provide the best traceability for our clients we have developed our own software platform that allows full customization to each one of our clients' needs," explains Zamorano.
Raul Zamorano, General Manager, iLogistica
iLogistica Santiago warehouse
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.